Skip to main content

Propel Bio Management, LLC

SEC CIK
0001969764
Latest filing
Aug 13, 2026

CORT holding history

Corcept Therapeutics Inc in every 13F filed by Propel Bio Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CORT overviewAll 13F holders of CORTFull Q2 2026 holdings

Shares (Q2 2026)
136,499
Value
$11.9M
% of portfolio
6.2%
Quarters held
2
Since Q1 2026
Holdings of CORT by Propel Bio Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026136,499$11.9M6.2%−11,329−7.7%ReducedHolders
Q1 2026147,828$6.02M3.8%+147,828NewHolders